MicheleLeeNassinMD
Pediatric Hematology & Oncology • Chicago, ILClinical Fellow in Pediatrics, Boston Children's Hospital
Dr. Nassin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5841 S. MARYLAND AVE.
M/C 2040
Chicago, IL 60637Phone+1 773-702-6808Fax+1 773-702-0414
Education & Training
Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 2010 - 2013
Rush Medical College of Rush University Medical CenterClass of 2010
Certifications & Licensure
UT State Medical License 2023 - 2026
IL State Medical License 2013 - 2023
MA State Medical License Active through 2013- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Haploidentical Hematopoietic Stem Cell Transplantation (HSCT) for Patients With Severe Sickle Cell Disease Start of enrollment: 2020 Apr 07
Publications & Presentations
PubMed
- 7 citationsEfficacy of post-induction therapy for high-risk neuroblastoma patients with end-induction residual disease.Ami V Desai, Mark A Applebaum, Theodore G Karrison, Akosua Oppong, Cindy Yuan
Cancer. 2022-08-01 - 11 citationsFamily Refusal of Chemotherapy for Pediatric Cancer Patients: A National Survey of Oncologists.Michele L. Nassin, Emily L. Mueller, Curt Ginder, Paul Kent
Journal of Pediatric Hematology/oncology. 2015-07-01 - 7 citationsIrreversible electroporation in the curative treatment of Ewing's sarcoma.Kacie Steinbrecher, Bulent Arslan, Michele L. Nassin, Paul Kent
BMJ Case Reports. 2016-09-21
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
